Profile: Neomatrix is a developer of innovative devices that allow women and doctors to promote optimal breast health. Our product, the HALO breast pap test, is the only fully automated, non-invasive breast cancer risk assessment test designed for use in the primary care setting. The HALO breast pap test is a safe and effective method to collect nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination, and/or differentiation of normal versus pre-malignant versus malignant cells. The test provides important benefits to clinicians such as routine NAF risk assessment and objective assessment for documentation. It is a consistent & reproducible, fully automated, user friendly test that requires no specialized training or certification. It can be performed by office staff & easily transported from room to room. It is a simple, 5 minutes procedure, and can be performed during annual check up.